InGell Labs operates from state-of-the-art R&D facilities operated by InnoCore Pharmaceuticals for formulation development and quality-assured synthesis and manufacturing of polymers.

Formulation development is currently performed up to the level of supplying formulations for animal trials and biocompatibility/tox studies.

The InGell-polymers are custom engineered for effective formulation development. Once selected, they are scaled-up towards the appropriate level by our partner PolyVation, where they can be manufactured according to cGMP-standards. 

Together with our partner InnoCore Pharmaceuticals we house new state-of-the-art labs and offices with access to class B/C clean room facilities enabling us to supply formulations for clinical uses.    

Polyvation mg 3690
Polyvation mg 3793

All analytical facilities needed to characterize the polymers and formulations are on board ranging from HPLC/UPLC, GPC/SEC, NMR to rheology, ELISA and more.

Our analytical practices are performed under the operational quality guidelines of InnoCore Pharamaceuticals, who is certified by KEMA for cGMP-analytical standards.